Bioteque (ROCO:4107) Cyclically Adjusted Book per Share: NT$44.50 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4107 Bioteque Corp ROCO:4107
85 GF Score
Price NT$117.00
GF Value NT$129.42
Valuation Modestly Undervalued
View Full Analysis

What is Bioteque Cyclically Adjusted Book per Share?

Bioteque ROCO:4107 -1.68% 85 Cyclically Adjusted Book per Share is NT$44.50 as of Dec. 2025. GuruFocus rates ROCO:4107 with a GF Score™ of 85/100 and a GF Value™ of NT$129.42 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bioteque's adjusted book value per share for the three months ended in Dec. 2025 was NT$52.053. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$44.50 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Bioteque's average Cyclically Adjusted Book Growth Rate was 6.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Bioteque was 12.50% per year. The lowest was 7.80% per year. And the median was 10.70% per year.

As of today (2026-07-17), Bioteque's current stock price is NT$117.00. Bioteque's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$44.50. Bioteque's Cyclically Adjusted PB Ratio of today is 2.63.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bioteque was 6.12. The lowest was 2.52. And the median was 3.29.


Bioteque  (ROCO:4107) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bioteque's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=117.00/44.50
=2.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bioteque was 6.12. The lowest was 2.52. And the median was 3.29.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bioteque Cyclically Adjusted Book per Share Related Terms


Bioteque Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Bioteque's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioteque Cyclically Adjusted Book per Share Chart

Bioteque Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.37 35.50 38.78 41.82 44.50

Bioteque Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.82 42.77 43.60 44.24 44.50

ROCO:4107 vs ISRG, BDX, MDLN: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, Bioteque's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioteque Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bioteque's Cyclically Adjusted PB Ratio falls into.


ROCO:4107
85GF Score
Bioteque Corp ROCO:4107
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioteque Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bioteque's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=52.053/324.0540*324.0540
=52.053

Current CPI (Dec. 2025) = 324.0540.

Bioteque Quarterly Data

Book Value per Share CPI Adj_Book
201603 28.734 238.132 39.102
201606 27.597 241.018 37.105
201609 28.564 241.428 38.340
201612 29.977 241.432 40.236
201703 30.254 243.801 40.213
201706 28.308 244.955 37.449
201709 29.603 246.819 38.866
201712 30.834 246.524 40.531
201803 31.852 249.554 41.361
201806 30.351 251.989 39.031
201809 31.716 252.439 40.714
201812 33.392 251.233 43.071
201903 35.091 254.202 44.734
201906 33.064 256.143 41.830
201909 34.689 256.759 43.781
201912 35.905 256.974 45.278
202003 37.518 258.115 47.102
202006 34.885 257.797 43.851
202009 36.489 260.280 45.430
202012 38.446 260.474 47.830
202103 40.196 264.877 49.176
202106 41.310 271.696 49.271
202109 38.587 274.310 45.584
202112 40.451 278.802 47.017
202203 37.942 287.504 42.766
202206 39.978 296.311 43.721
202209 42.383 296.808 46.274
202212 43.753 296.797 47.771
202303 40.626 301.836 43.616
202306 42.269 305.109 44.894
202309 44.651 307.789 47.011
202312 46.035 306.746 48.633
202403 43.661 312.332 45.300
202406 45.534 314.175 46.966
202409 47.453 315.301 48.770
202412 49.655 315.605 50.984
202503 46.710 319.799 47.331
202506 47.477 322.561 47.697
202509 49.574 324.800 49.460
202512 52.053 324.054 52.053

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$44.50 mean?
Bioteque (ROCO:4107) has a Cyclically Adjusted Book per Share of NT$44.50 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bioteque and its competitors.
Is Bioteque's Cyclically Adjusted Book per Share too high?
Bioteque's current Cyclically Adjusted Book per Share is NT$44.50. Overall, Bioteque has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's Cyclically Adjusted Book per Share compare to ISRG and BDX?
Bioteque's Cyclically Adjusted Book per Share of NT$44.50 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bioteque and its competitors. Bioteque's current Cyclically Adjusted Book per Share is NT$44.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$129.42, compared to a current price of NT$117.00 — trading 9.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$44.50. Bioteque's overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current Cyclically Adjusted Book per Share is NT$44.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioteque (ROCO:4107) Overvalued in 2026?

Based on GuruFocus' analysis, Bioteque stock appears to be undervalued. The current stock price of NT$117.00 is trading 9.6% below its estimated GF Value™ of NT$129.42. GuruFocus considers Bioteque to be Modestly Undervalued.

Key valuation signals for ROCO:4107:

  • Cyclically Adjusted Book per Share: NT$44.50
  • GF Value™: NT$129.42 vs. price of NT$117.00 (9.6% below fair value)
  • GF Score™: 85/100

No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioteque Business Description

Address Chang-An E. Road, 5th Floor-6, No.23, Section 1, Taipei, TWN, 104
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
85GF Score

Get the complete analysis for ROCO:4107

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$117.00
Price
NT$129.42
GF Value